Current Pricing Information
The most recent wholesale price for a package of 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE is $11.04239 per billable unit.Adhansia Xr is a a human prescription drug labeled by Adlon Therapeutics L.p. and is priced per "EA" unit. The pricing information is based on the National Average Drug Acquisition Cost (NADAC) and is effective since 08-17-2022.
NADAC pricing data is based on random monthly surveys and reflects the average drug invoice price paid by retail community pharmacies to wholesalers. The data source for this pricing survey was a C/I - Chain or Independent Pharmacy.
The Centers for Medicare and Medicaid Services (CMS) compile the NADAC data based on random monthly surveys on more than 60,000 pharmacies from all 50 states and the District of Columbia. NADAC pricing information is NOT the price paid by end-customers but instead the price paid by pharmacies to drug wholesalers and distributors.View Package Details
The NADAC wholesale price of Adhansia Xr 72912-535-30 has fluctuated from a low of $10.46059 to a high of $11.04239 per billable unit over a period of 1 year and 4 months. The historical price table below includes all the price changes based on the monthly surveys of retail and chain pharmacies taken by the Centers for Medicare and Medicaid Services (CMS).
|Effective Date||Price per Unit||Pricing Unit||Pharmacy Type Indicator||Explanation Code||Classification Rate Setting|
|08-17-2022||$11.04239||EA||C/I - Chain or Independent Pharmacy||Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.||B - Brand|
|01-01-2022||$10.95747||EA||C/I - Chain or Independent Pharmacy||Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.||B - Brand|
|04-21-2021||$10.46059||EA||C/I - Chain or Independent Pharmacy||Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.||B - Brand|
The pricing data in this page is based on the National Average Drug Acquisition Cost (NADAC). The NADAC data is compiled by CMS and updated every week. The NADAC dataset is designed to help create a national benchmark reflective of the wholesale prices paid by retails pharmacies to acquire prescription and over-the-counter drugs. The pricing information in this page reflects the reference point that healthcare programs like Medicaid may use to reimburse pharmacies. The pricing data is this page is NOT the price paid by end-customers.
NADAC Pricing Data Last Updated on: September 21, 2022